
Pi™ Prostate AI with expert level performance
Lucida Medical develops software to help clinicians find cancer, using AI and MRI.
What clinicians say
‘Pi can identify the most clinically significant cancers and essentially allow me to offer a same day pathway to those patients. MRi in the morning, biopsy in the afternoon’
Dr Oliver Hulson
Consultant Interventional Radiologist
St James University Hospital Leeds

Case reports
Pi™ helps find a high-grade prostate cancer
Case notes:
The reporting radiologist initially thought that this man’s prostate was normal. However, reviewing the Pi™ output, they noted this lesion highlighted by AI in the apex, an area that can be easily overlooked. Biopsy found Gleason 9 high-grade prostate cancer.
Patient impact:
High-grade prostate cancer requires urgent treatment to stop it spreading. Early detection in this case should enable the man to benefit greatly from appropriate treatment.

Video – example cases
Upcoming conferences
Find out more at these events:
Get in touch, book a demo
To find out more, please contact us via this form
Latest News

Macmillan Cancer Support is investing in Lucida Medical, a spin-off from the University of Cambridge that develops Pi™ software to help radiologists find cancer

Lucida Medical Ltd announces a distribution agreement with Sectra to offer Pi AI technology to help diagnose prostate cancer

Somerset’s NHS pioneers clinical use of AI software to transform prostate cancer diagnosis

Blackford and Lucida Medical partner to enhance prostate care
Our Partners

